A single dose of aprotinin prevents platelet hyporeactivity after coronary artery bypass graft surgery

Polskie Archiwum Medycyny Wewnetrznej

Volumn 120, Issue 9, 2010, Pages 321-327

  Szczeklik, Wojciech ^a   Morawski, Włodzimierz ^b   Sanak, Marek ^a   Jakieła, Bogdan ^a   Bolkowski, Maciej ^b   Cisowski, Marek ^b   Szczeklik, Michał ^b   Bochenek, Andrzej ^b   Musiał, Jacek ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Aprotinin; Coronary artery bypass graft; Platelet function

Indexed keywords

ADENOSINE DIPHOSPHATE; APROTININ; GLYCOPROTEIN IIB; PADGEM PROTEIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE 6; THROMBOXANE A2; ANTITHROMBOCYTIC AGENT; HEMOSTATIC AGENT; PROTHROMBIN; THROMBIN; THROMBIN RECEPTOR;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IN VITRO STUDY; MALE; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; METHODOLOGY; MIDDLE AGED; PEROPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; THROMBOCYTE; TREATMENT OUTCOME;

AGED; APROTININ; BLOOD LOSS, SURGICAL; BLOOD PLATELETS; CORONARY ARTERY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOSTATICS; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; POSTOPERATIVE HEMORRHAGE; PROTHROMBIN; THROMBIN; TREATMENT OUTCOME;

EID: 79952118574     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.957     Document Type: Article

References (20)

1. Dacey LJ, Munoz JJ, Baribeau YR, et al. Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study Group. Arch Surg. 1998; 133: 442-447.
2. Peters DC, Noble S. Aprotinin: an update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery. Drugs. 1999; 57: 233-260. (Pubitemid 29116517)
3. Altan H, Bozkurt AK, Arslan C, et al. Serine protease inhibitor aprotinin ameliorates renal injury in a rat model of ischemia-perfusion injury. Transplant Proc. 2009; 41: 1512-1516.
4. McEvoy MD, Reeves ST, Reves JG, Spinale FG. Aprotinin in cardiac surgery: a review of conventional and novel mechanisms of action. Anesth Analg. 2007; 105: 949-962. (Pubitemid 47479307)
5. Mangano DT, Miao Y, Vuylsteke A, et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA. 2007; 297: 471-479.
6. Fergusson DA, Hébert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008; 358: 2319-2331. (Pubitemid 351749156)
7. Musial J, Niewiarowski S, Rucinski B, et al. Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins. RGD-containing peptides from viper venoms. Circulation. 1990; 82: 261-273.
8. Day JR, Haskard DO, Taylor KM, Landis RC. Effect of aprotinin and recombinant variants on platelet protease-activated receptor 1 activation. Ann Thorac Surg. 2006; 81: 619-624. (Pubitemid 43120566)
9. Morawski W, Sanak M, Cisowski M, et al. Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: role of aspirin and platelet glycoprotein IIIa polymorphism. J Thorac Cardiovasc Surg. 2005; 130: 791-796. (Pubitemid 41265721)
10. Dropinski J, Jakiela B, Sanak M, et al. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin. Thromb Haemost. 2007; 98: 201-209. (Pubitemid 47074197)
11. Catella F, FitzGerald GA. Paired analysis of urinary thromboxane B2 metabolites in humans. Thromb Res. 1987; 47: 647-656. (Pubitemid 18032523)
12. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000; 36: 959-969.
13. Whitson BA, Huddleston SJ, Savik K, Shumway SJ. Bloodless cardiac surgery is associated with decreased morbidity and mortality. J Card Surg. 2007; 22: 373-378. (Pubitemid 47353012)
14. Alvarez JM, Jackson LR, Chatwin C, Smolich JJ. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial. J Thorac Cardiovasc Surg. 2001; 122: 457-463. (Pubitemid 32843943)
15. Dietrich W, Spannagl M, Boehm J, et al. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin. Anesth Analg. 2008; 107: 1469-1478.
16. Goudeau JJ, Clermont G, Guillery O, et al. In high-risk patients, combination of antiinflammatory procedures during cardiopulmonary bypass can reduce incidences of inflammation and oxidative stress. J Cardiovasc Pharmacol. 2007; 49: 39-45.
17. Ronald A, Dunning J. Does use of aprotinin decrease the incidence of stroke and neurological complications in adult patients undergoing cardiac surgery? Interact Cardiovasc Thorac Surg. 2006; 5: 767-773.
18. The European Medicines Agency (EMEA) statetment concerning aprotinin use. http://www.ema.europa.eu/pdfs/human/press/pr/53467807en.pdf. Accessed June 12, 2010.
19. Day JR, Punjabi PP, Randi AM, et al. Clinical inhibition of the seven- -transmembrane thrombin receptor (PAR1) by intravenous aprotinin during cardiothoracic surgery. Circulation. 2004; 110: 2597-2600. (Pubitemid 39453008)
20. Kozek-Langenecker SA, Mohammad SF, Masaki T, et al. The effects of aprotonin on platelets in vitro using whole blood flow cytometry. Anesth Analg. 2000; 90: 12-16. (Pubitemid 30022960)